Adjust in time: beware of the challenges Annex VI brings for labelling

prism_010819.jpg

Gordon Alexander and Simon Jones outline how imminent changes to EU clinical trial regulations will have major implications for labelling processes.

 ALREADY A REGISTERED USER? SIGN IN now

 

REGISTER FOR FREE TO CONTINUE READING THIS ARTICLE

And get access to unlimited world-class packaging reporting and commentary.